Why it matters: complaints reveal the quality issues customers already sense, and handling them proves you act before regulators do.
Complaint handling keeps post-market signals visible, connected to quality events, and answered with defensible decisions.
Complaint-handling expectations flow through FDA, EU, MHRA, and ICH documents:
Regulatory callout: regulators expect documented complaint review, QA-signoff, and trending that links complaints to CAPA or recalls when required.
Inspectors ask whether complaint handling closes the loop:
Inspector insight: gaps, slow responses, or missing trending data turn the complaint book into a warning letter trigger.
Complaint handling failures often mirror poor quality oversight:
Failure callout: mixing customer talk and regulatory data in the same record keeps everyone honest.
A modern eQMS keeps complaint evidence connected and retrievable:
Complere stitches complaints into the wider quality context so you can defend how signals were handled and what followed.
FDA 21 CFR 211, EU GMP Chapter 8, MHRA, and PIC/S expect formal complaint records, trending, and product-quality impact analysis.
Complere links complaints to deviations, CAPA, document control, and training so you can show complete follow-through in one traceable record.
Inspectors look for classification, investigation documentation, linkage to CAPA or recalls, and evidence that trends are analyzed.
Complaint handling captures customer signals, investigates their impact on quality or safety, and feeds corrective or preventive action to protect patients.
Complaint handling in regulated pharma demands documented investigations, risk assessments, and linkage to CAPA, not just resolving a ticket.
Complere helps regulated teams manage complaint records in a controlled quality workflow so review decisions, linked actions, and supporting evidence are easier to follow and defend.
Audit ready | Stronger complaint traceability | Better follow-through
